Ballentine Partners, LLC Organon & Co. Transaction History
Ballentine Partners, LLC
- $5.81 Billion
- Q4 2024
A detailed history of Ballentine Partners, LLC transactions in Organon & Co. stock. As of the latest transaction made, Ballentine Partners, LLC holds 17,155 shares of OGN stock, worth $264,015. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,155
Previous 19,305
11.14%
Holding current value
$264,015
Previous $369,000
30.89%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding OGN
# of Institutions
813Shares Held
201MCall Options Held
1.53MPut Options Held
1.07M-
Black Rock Inc. New York, NY32.6MShares$501 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.4MShares$468 Million0.01% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.2MShares$172 Million0.41% of portfolio
-
Massachusetts Financial Services CO Boston, MA9.9MShares$152 Million0.05% of portfolio
-
State Street Corp Boston, MA9.34MShares$144 Million0.01% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $3.91B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...